The Potential Role of Telomerase Reverse Transcriptase Promoter Mutations asNon-Invasive Urinary Biomarkers in Bladder Cancer Detection: Is the New Droplet Digital Assay (ddPCR) Reliable to be Clinically Used?
gene mutations have been hailed as the most common bladder cancer mutations. UroMuTERT® and ddPCR tests evaluate the mutations in the urinary DNA. This study aims to evaluate the validity ... underwent a complete…

